Adjuvant mitotane for adrenocortical cancer--working through uncertainty.
Terzolo
M
M
Department of Clinical and Biological Sciences, Internal Medicine I, University ofTurin, Orbassano 10043, Italy. terzolo@usa.net
Fassnacht
M
M
Ciccone
G
G
Allolio
B
B
Berruti
A
A
D000306:Adrenal Cortex Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy* / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008939:Mitotane / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D035501:Uncertainty
D018931:Antineoplastic Agents, Hormonal; D008939:Mitotane